NY study: Pfizer vax far less effective in younger kids than teens and adultsBy Selim Algar
February 28, 2022
Pfizer’s COVID-19 vaccine is far less effective for younger children than for teens and adults, according to a new study.
New York state health officials found that the two-dose jab offers minimal protection against infection for kids aged 5 to 11 about a month after full vaccination.
“In the Omicron era, the effectiveness against cases of [the Pfizer-BioNTech vaccine] declined rapidly for children, particularly those 5-11 years,” the authors of the study wrote.
The Pfizer shot is the only COVID-19 vaccine currently approved by the feds for kids ages 5 to 11.
Still, the study — undertaken at the height of the Omicron variant surge in December and January — found that the vaccines did offer significant protection against severe illness.
“Vaccination of children 5-11 years was protective against severe disease and is recommended,” the authors said.
But the report also suggested that dosing regimens for kids be reconsidered in light of the underwhelming results.
* * *
Source:
https://nypost.com/2022/02/28/ny-study-pfizer-vax-far-less-effective-in-younger-kids/
